Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. AAPL
4. ACN
5. IONS
6. AZN
7. ROIV
8. HOOD
9. QCOM
10. NVDA

Go back to Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology
(NASDAQ: NRIX) Delayed: 26.26 +0.12 (0.46%)
Previous Close $26.14    52 Week High $ 
Open $25.42    52 Week Low $ 
Day High $26.42    P/E N/A 
Day Low $25.36    EPS $ 
Volume 637,621       

Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 54.10 -0.87 (1.58%)
Previous Close $54.97    52 Week High $35.13 
Open $54.24    52 Week Low $28.10 
Day High $54.42    P/E N/A 
Day Low $53.87    EPS $0.00 
Volume 739,699       

Brown & Brown, Inc. (NYSE: RO) Delayed: 8.49 +0.55 (6.93%)
Previous Close $7.94    52 Week High $8.59 
Open $7.94    52 Week Low $7.82 
Day High $8.59    P/E 6.53 
Day Low $7.82    EPS $1.30 
Volume 42,732       

Roper Industries (NASDAQ: ROP) Delayed: 394.96 -12.32 (3.02%)
Previous Close $407.28    52 Week High $195.93 
Open $401.92    52 Week Low $155.79 
Day High $403.00    P/E 73.55 
Day Low $394.38    EPS $5.37 
Volume 153,477